Fosun International LTD Ultragenyx Pharmaceutical Inc. Transaction History

Fosun International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$42.5 - $63.11 $2.3 Million - $3.42 Million	-54,144 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$54.93 - $74.36 $439,440 - $594,880	8,000 Added 17.34%	54,144 $3.36 Million
Q1 2019 May 10, 2019	BUY	$39.87 - $69.36 $843,011 - $1.47 Million	21,144 Added 84.58%	46,144 $3.15 Million
Q4 2018 Jan 31, 2019	SELL	$38.89 - $77.3 $525,015 - $1.04 Million	-13,500 Reduced 35.06%	25,000 $1.05 Million
Q3 2018 Nov 09, 2018	BUY	$71.81 - $90.15 $2.76 Million - $3.47 Million	38,500 New	38,500 $3.07 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.15B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.